Meticulous Research®, leading global market research company published a research report titled, “The Global Vaccines Market is projected to $57.50 billion by 2025 growing at a CAGR of 7.9% during the forecast period of 2018 to 2025.”
The Global Vaccines Market study presents historical market data in terms of values (2016 and 2017), estimated current data (2018), and forecasts for 2025-Vaccines Market By Indication (Pneumococcal, Influenza, DTP, HPV, Hepatitis, Meningococcal, Rotavirus, Polio, MMR), Type (Live, Toxoid), Route Of Administration (IM, SC, Oral), Valence (Monovalent, Multivalent) And Geography.
In 2017, the pneumococcal disease accounted for the largest share of the global vaccines market. The large share of this segment is mainly attributed to the high prevalence of pneumococcal disease in pediatric, elderly, and immunocompromised populations. In addition, growing number of pneumococcal diseases associated with chronic disease patients is further driving the adoption of pneumococcal vaccines. However, meningococcal disease vaccine segment is expected to grow at the highest CAGR in the next 5-7 years.
The growth of this market is mainly attributed to high prevalence of diseases, increasing government initiatives towards immunization, rising adoption of vaccines, technological advancement in vaccine industry, and strong pipeline for vaccines.
The global vaccines market is highly competitive with the presence of many players worldwide. With four big pharmaceutical companies; GSK, Merck & Co., Inc., Pfizer, and Sanofi, the vaccine industry is highly consolidated. CSL Limited, Emergent BioSolutions, Johnson and Johnson, Serum Institute of India, Daiichi Sankyo, Takeda and AstraZeneca are the other leading players of the global vaccines market. All these players are focusing more on technologically-advanced vaccine products.
Read full Research Report Study On
North America accounted for the largest share of the vaccines market with its well-established vaccination program. In addition, factors such as the increasing prevalence of diseases, growing adoption of advanced vaccines, and large pool of key players are further expected to propel the growth of vaccines market in this region.The intramuscular accounted for the largest share of the vaccines market. The large share of this segment is mainly due to the availability of wide range of vaccines for IM.
Key Topics Covered in This Report:
The Asia-Pacific vaccines market is expected to grow at the highest CAGR of 8.9%. The growth in the APAC market is mainly attributed to large patient pool, rising prevalence of diseases, growing awareness on vaccination, increasing government initiatives, and expanding presence of key players in this region. In addition, increasing disposable income and growing awareness about heath in emerging countries are further propelling the demand for vaccines in APAC region.
Hurry Up To Get Your Free Sample Report Now!
Direct Lines: +1-646-781-8004 (North America)
+91 744-7780008 (Asia-Pacific)